Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of Eg5 correlates with high grade astrocytic neoplasm

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To investigate the relationship between Eg5 and histopathological grade of astrocytoma, Eg5 expression was evaluated by immunohistochemical examination on 88 specimens including 25 cases of glioblastoma (WHO grade IV), 22 cases of anaplastic astrocytoma (WHO grade III), 20 cases of diffuse astrocytoma (WHO grade II), and 21 cases of pilocytic astrocytoma (WHO grade I). The histopathological characteristics and Eg5 expression level of each tumor were assessed and statistically analyzed. Astrocytic tumors exhibited significant correlation of expression of Eg5 with higher WHO histopathological grades (p < 0.001). Eg5 is expressed in 51–98 % (mean 76.88 %) of neoplastic cells in glioblastoma, 34–57 % (mean 43.59 %) of neoplastic cells in anaplastic astrocytoma, 6–36 % (mean 18.60 %) of neoplastic cells in diffuse astrocytoma, and 2–28 % (mean 13.48 %) of neoplastic cells in pilocytic astrocytoma. In conclusion, overexpression of Eg5 associates with high-grade astrocytic neoplasm, and it may represent an independent diagnostic and prognostic factor in grading astrocytic tumors and predicting prognosis of astrocytic tumor patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sun D, Lu J, Ding K, Bi D, Niu Z, Cao Q, Zhang J, Ding S (2013) The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma. Med Oncol 30(1):476

    Article  PubMed  Google Scholar 

  2. Ding S, Xing N, Lu J, Zhang H, Nishizawa K, Liu S, Yuan X, Qin Y, Liu Y, Ogawa O, Nishiyama H (2011) Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma. Int J Urol 18(6):432–438

    Article  CAS  PubMed  Google Scholar 

  3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon

    Google Scholar 

  4. Kashina AS, Baskin RJ, Cole DG, Wedaman KP, Saxton WM, Scholey JM (1996) A bipolar kinesin. Nature 379:270–272

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Kapitein LC, Peterman EJ, Kwok BH, Kim JH, Kapoor TM, Schmidt CF (2005) The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks. Nature 435:114–118

    Article  CAS  PubMed  Google Scholar 

  6. Hansen GM, Justice MJ (1999) Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. Oncogene 18:6531–6539

    Article  CAS  PubMed  Google Scholar 

  7. Castillo A, Morse HC 3rd, Godfrey VL, Naeem R, Justice MJ (2007) Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res 67:10138–10147

    Article  CAS  PubMed  Google Scholar 

  8. Wordeman L (2010) How kinesin motor proteins drive mitotic spindle function: lessons from molecular assays. Semin Cell Dev Biol 21:260–268

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y (2012) Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol 47:351–358

    Article  PubMed  Google Scholar 

  10. Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabala JC, Gonzales P, Roth S, Weitman S, Wood KW (2004) Antitumor activity of a kinesin inhibitor. Cancer Res 64:3276–3280

    Article  CAS  PubMed  Google Scholar 

  11. Herrup Karl, Yang Yan (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 8:368–378

    Article  CAS  PubMed  Google Scholar 

  12. Tao W, South VJ, Diehl RE, Davide JP, Sepp-Lorenzino L, Fraley ME, Arrington KL, Lobell RB (2007) An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Mol Cell Biol 27:689–698

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286:971–974

    Article  CAS  PubMed  Google Scholar 

  14. Liu L, Parameswaran S, Liu J, Kim S, Wojcik EJ (2011) Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms. J Biol Chem 286(8):6201–6210

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Nakai R, Iida S, Takahashi T, Tsujita T, Okamoto S, Takada C, Akasaka K, Ichikawa S, Ishida H, Kusaka H, Akinaga S, Murakata C, Honda S, Nitta M, Saya H, Yamashita Y (2009) K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells. Cancer Res 69:3901–3909

    Article  CAS  PubMed  Google Scholar 

  16. Perez-Melero C (2014) KSP Inhibitors as antimitotic agents. Curr Top Med Chem 14(20):2286–2311

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Louisiana State University School of Medicine, 1901 Perdido Street, New Orleans, LA, 70112, USA

    Liqiong Liu

  2. Section of Neuropathology, Department of Pathology, Tulane University School of Medicine, 1430 Tulane Ave., SL-79, New Orleans, LA, 70112-2632, USA

    Xichun Liu, Haitao Zhang & Zhenggang Xiong

  3. Department of Neurosurgery, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans, LA, 70112-2632, USA

    Marcus Mare & Aaron S. Dumont

  4. Department of Structural and Cellular Biology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans, LA, 70112-2632, USA

    Dong Yan

Authors
  1. Liqiong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xichun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcus Mare
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aaron S. Dumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haitao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhenggang Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhenggang Xiong.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Liu, X., Mare, M. et al. Overexpression of Eg5 correlates with high grade astrocytic neoplasm. J Neurooncol 126, 77–80 (2016). https://doi.org/10.1007/s11060-015-1954-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-1954-3

Keywords

Search

Navigation